Aingo Pharma

Chandigarh, India
Manufacturer of powder, capsules, syrup, injectables, and tablets

About Aingo Pharma

Aingo Pharma is a Healthcare company based in Chandigarh (India). Manufacturer of powder, capsules, syrup, injectables, and tablets. It operates on a Traditional Pharmaceuticals model. Its chief executive, as recorded, is Ram Gopal. Its Indian entity Aingo Pharma Private Limited reported revenue of β‚Ή6.77 Cr. Aingo Pharma offers products and services including Aingo Pharma Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.

Company details

Aingo Pharma operates with a Traditional Pharmaceuticals model, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of powder, capsules, syrup, injectables, and tablets. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Key Metrics
  • Annual Revenue
    ₹6.77 Cr

    FY 2024 · +15% YoY

  • Net Profit
    ₹9.5 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹21.6 Lakh

    FY 2024 · 3% margin

Products & Services of Aingo Pharma

Aingo Pharma offers a comprehensive portfolio of products and services, including Aingo Pharma Platform.

Aingo Pharma Platform
Healthcare

Manufacturer of powder, capsules, syrup, injectables, and tablets

Board of directors of Aingo Pharma Private Limited (Aingo Pharma)

Aingo Pharma Private Limited is the primary company behind Aingo Pharma. The board of Aingo Pharma Private Limited currently have 2 directors; the longest-serving is Sanjay Kumar Garg, appointed in 2014. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sanjay Kumar Garg
DIN 02756187
Director18 Aug 201412 yrs 2 moAingo Pharma Private Limited
Ram Gopal
DIN 07033186
Director05 Dec 201411 yrs 10 moAingo Pharma Private Limited

People of Aingo Pharma

1 people are tracked at Aingo Pharma (1 in leadership).

NameRoleGroup
CEOLeadership
Premium access

Complete people profiles for Aingo Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Aingo Pharma

Figures of Aingo Pharma Private Limited, the primary company behind Aingo Pharma, for FY 2024. Revenue was ₹6.77 Cr (+15% year on year). Net profit was ₹9.5 Lakh (1% margin). EBITDA was ₹21.6 Lakh (3% margin). Revenue has grown at a compounded annual rate of +18% over three years and +10% over five years.

  • ₹6.77 CrRevenue · FY 2024 · +15% YoY
  • ₹9.5 LakhNet profit · 1% margin
  • ₹21.6 LakhEBITDA · 3% margin
  • ₹1 LakhPaid-up capital
  • +18%Revenue CAGR, 3 years
  • +10%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aingo Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Aingo Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aingo Pharma

Aingo Pharma is headquartered in Chandigarh, India.

Ram Gopal is the CEO of Aingo Pharma, as recorded in our data.

The primary company behind Aingo Pharma, Aingo Pharma Private Limited, reported revenue of β‚Ή6.77 Cr for FY 2024, up 15% year on year.

Aingo Pharma operates with a Traditional Pharmaceuticals model, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of powder, capsules, syrup, injectables, and tablets. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Aingo Pharma offers Aingo Pharma Platform.

Aingo Pharma operates through Aingo Pharma Private Limited.

The legal entities of Aingo Pharma currently have 2 directors, including Ram Gopal, Sanjay Kumar Garg.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available